MedTrace Logo

Effect of Moringa Oleifera Infusion on Health

NCT04314258 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2020-03-19

No results posted yet for this study

Summary

The study aims at investigating the effects of the consumption of Moringa oleifera Lam leaves on biomedical markers of health among healthy individuals who are hyperglycaemic with a fasting blood glucose equal or greater than 5.5mmol/L.

The main objectives are as follows:

1. To determine the effect of consuming 4 grams of Moringa oleifera Lam leaves infused in 200 ml of hot water twice daily on blood glucose level \[BSc (Hons) Medical Science Student\].
2. To assess the effect of consuming 4 grams of Moringa oleifera Lam leaves infused in 200 ml of hot water twice daily on plasma lipids level \[Master of Public Health Students\].
3. To compare the effect of the Moringa tea consumption on lipid profiles of both healthy and hyperglycemic participants \[Master of Public Health Students\].
4. To evaluate the effects of Moringa oleifera Lam leaves on blood anti-oxidant status \[BSc (Hons) Nutritional Sciences Student\].

The research work will consist of (1) Experimental intervention: The experimental group will drink Moringa tea; (2) Survey questionnaire, (3) Anthropometric measurements, (4) Blood pressure determination and (5) Blood collections at 15-day intervals during 9 weeks. The blood tests to be performed are as follows: Glucose, HbA1C, Uric acid, C-Protein reactive, Lipid Profile (Total Cholesterol, HDL Cholesterol, Triglycerides), and blood antioxidants (superoxide dismutase, glutathione peroxidase, total blood anti-oxidant capacity).

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Moringa oleifera tea

4 grams of Moringa oleifera tea twice daily

Sponsors & Collaborators

  • University of Mauritius

    lead OTHER

Principal Investigators

  • Marie CHAN SUN, PhD · University of Mauritius

  • Vidushi NEERGHEEN, PhD · University of Mauritius

  • Abha JODHEEA-JUTTON, MD · University of Mauritius

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2020-04-30
Completion
2020-08-31

Countries

  • Mauritius

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04314258 on ClinicalTrials.gov